Key result
Higher NPAR is linked to CKD mortality with modest discriminative ability.
Why the study?
Does an elevated Neutrophil Percentage-To-Albumin Ratio (NPAR) predict all-cause and cardiovascular mortality in patients with chronic kidney disease?
Observational
Does an elevated Neutrophil Percentage-To-Albumin Ratio (NPAR) predict all-cause and cardiovascular mortality in patients with chronic kidney disease?
Answers are grounded in this paper and cite their sources.
Elevated NPAR is associated with a higher likelihood of cardiovascular and all-cause mortality in patients with CKD, suggesting its potential as a prognostic biomarker.
value <0.001. ROC analysis showed that NPAR had modest discriminative ability for predicting all-cause mortality (AUC = 0.601), with an optimal cutoff value of 1.48. Across different subgroups, NPAR reliably predicted CVD and all-cause mortality in CKD patients.ConclusionElevated NPAR were linked with a higher likelihood of CVD mortality and all-cause mortality in patients with CKD and could serve as an effective prognostic biomarker.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted an observational in Chronic Kidney Disease. Neutrophil Percentage-To-Albumin Ratio (NPAR) was evaluated on All-cause mortality (AUC 0.601, p=<0.001). Elevated Neutrophil Percentage-To-Albumin Ratio (NPAR) demonstrated modest discriminative ability for predicting all-cause mortality in patients with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: